Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: J Am Geriatr Soc. 2008 Dec 10;57(2):260–265. doi: 10.1111/j.1532-5415.2008.02097.x

Table 2.

Adjusted Association of Stopping to Rest with Mobility Disability at Follow-up.

Variable Model 1 Model 2 Model 3 Model 4 Model 5* Model 6* Model 7*
Rest Stop Status
 REST 5.4 (2.7, 10.9) 2.5 (1.1, 5.5) 4.3 (2.1, 9.0) 2.6 (1.2, 5.9) 3.7 (1.8, 7.7) 5.0 (2.5, 10.1) 2.1 (0.9, 4.9)
 NO-REST (Ref)
400-meter walking time, minutes 1.5 (1.3, 1.8) 1.4 (1.1, 1.6) 1.3 (1.1, 1.6)
SPPB, score 0.6 (0.5, 0.7) 0.7 (0.5, 0.8) 0.7 (0.5, 0.9)
Limited in walking a mile
 Missing (n=64) 2.9 (0.8, 10.2) 1.7 (0.4, 6.6)
 Limited a lot 5.7 (2.1, 15.3) 3.6 (1.3, 10.4)
 Not limited (Ref)
Walking efficacy 5 laps 0.4 (0.2, 0.8) 0.5 (0.2, 1.0)
Lower limb arthritis 0.9 (0.4, 2.0) 1.2 (0.5, 2.6)
BMI 1.0 (1.0, 1.1) 1.0 (1.0, 1.1)

Note: Results are presented as odds ratios (95% confidence interval). Association of stopping to rest with mobility disability is in the full model (Model 7) adjusted for age, sex, clinic site, 400-meter walking time, Short Physical Performance Battery (SPPB) score, limitation in walking 1 mile, self-efficacy in walking 5 laps of the 400 meter walk (100 m), lower limb arthritis and Body Mass Index (BMI). Separate models are adjusted as follows: 1. Age, sex, clinic site (individual estimates for these not shown any of the models). 2. Model 1 + 400-meter walking time. 3. Model 1 + SPPB. 4. Model 2 + SPPB. 5. Model 1 + limited in walking 1 mile and walking efficacy 5 laps. 6. Model 1 + lower limb arthritis and BMI. 7. Full model. REST and NO-REST denote groups of participants stopping to rest or not during the 400-meter walk test. SPPB denotes Short Physical Performance Battery.

*

Measures of walking efficacy and lower limb arthritis each had one missing participant (see Table 1) who were excluded from the models.